WithdrawnPhase 3NCT01142414

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Studying Squamous cell carcinoma of oral cavity and lip

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator
Wilfried Budach, MD, MD
Heinrich-Heine University, Duesseldorf
Intervention
panitumumab(biological)
Eligibility
18-75 years · All sexes

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01142414 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of oral cavity and lip

← Back to all trials